See original release here HALIFAX, Nova Scotia–(BUSINESS WIRE)–Athletigen Technologies unveiled today the closed release of Iris™, powered by proprietary human performance insights gleaned from their partnerships with world class athletes and performance experts. Iris™ is the first of its kind personalized performance genomics app suite, which merges an athlete’s genetic predispositions with daily monitoring data, empowering coaches and athletes with actionable insights to inform peak performance in training and competition. Built specifically for high performance athletes, Iris™ sits at the intersection of nature and nurture; where an athlete’s genetic traits interface with their environment. After analyzing an athlete’s DNA through a saliva sample, Athletigen reports on genetic markers related to nutrition, recovery and injury protection that can affect training adaptation and performance. Combining genetic insights with daily athlete monitoring of sleep, hunger, mood, training load and more, athletes and coaches are provided a holistic view of human performance data. “Genetics is one very important piece of the human performance puzzle,” explains Dr. Jeremy Koenig, Founder & CEO of Athletigen. “We built Iris to empower athletes to understand how their performance training can be augmented through an understanding of their genetic foundation especially when considered in combination with variables that coaches have considered for more than half a century.” Consisting of the Iris™ Athlete app and Iris™ Coach app, the software suite was built working closely with Olympic athletes and coaches at the ALTIS training center in Phoenix, AZ leading up to the Rio 2016 games. Starting this fall, ALTIS athletes & coaches will be using Iris™ as Athletigen’s official partner and pioneer of human performance research. “Athletigen have taken the hard science behind genetics and its role in athletic performance, meticulously sifted through the noise and wealth of research available to create a product that gives coaches and other practitioners accurate and valuable information about the individuals they work with,” says Mike Boykin, Program Manager & Sprints Coach at ALTIS. “Athletigen uniquely understands that their insight does not replace the information already available, but instead serves to paint a broader picture of each athlete’s gifts and opportunities. At ALTIS, we have not only applied the genetic information to make more informed decisions about an athlete’s, macro, meso, and micro structure of training, but also plan on using their daily monitoring app to better track and make adjustments to the acute and chronic loads we place upon each athlete.” Athletigen is a company driven by science and committed to helping athletes achieve their performance goals. Through genomic innovation with strategic partners, Athletigen works to deliver the most advanced research findings in human performance to its customers. Iris™ is available to select high performance organizations, with the expected release to the general public next year. For more information, visit www.athletigen.com.
- Densitas Software Wins Procurement For DIMASOS Breast Screening Trial In Germany
- ENTREVESTOR: IMV Inc. entering a crucial phase in late 2019
- Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million
- IMV Announces Research Collaboration with The Wistar Institute to Develop New Targeted Immunotherapy Against the Common BRAF Cancer Mutation
- ACOA NEWS RELEASE: Panag Pharma providing effective, non-addictive plant-based pain management